Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation

Previously, the authors have identified that c-Met mediates reactivation of the PI3K/AKT pathway following BRAF inhibitor treatment in BRAF (V600E) mutant anaplastic thyroid cancer, thereby contributing to the acquired drug resistance. Therefore dual inhibition of BRAF and c-Met led to sustained tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Byeon, Hyung Kwon, Na, Hwi Jung, Yang, Yeon Ju, Ko, Sooah, Yoon, Sun Och, Ku, Minhee, Yang, Jaemoon, Kim, Jae Wook, Ban, Myung Jin, Kim, Ji-Hoon, Kim, Da Hee, Kim, Jung Min, Choi, Eun Chang, Kim, Chang-Hoon, Yoon, Joo-Heon, Koh, Yoon Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352181/
https://www.ncbi.nlm.nih.gov/pubmed/27880942
http://dx.doi.org/10.18632/oncotarget.13480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352181/
https://www.ncbi.nlm.nih.gov/pubmed/27880942
http://dx.doi.org/10.18632/oncotarget.13480

Ejemplares similares